DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
![Healthcare technology patient-GettyImages-1216544361]( "Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity")
Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data IntegrityGetting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
-
![Cloud computing digita-GettyImages-2161057424]( "From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials")
From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical TrialsDiscover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.
DCT TECHNOLOGY VIDEOS
IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.
Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
DCT TECHNOLOGY RESOURCES
-
![How To Spec, Purchase, And Implement The Right IRT System For Your Clinical Trial]( "Ready For Remote: eCOA Adapts To A Hybrid World")
Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.
-
![GettyImages-1163698800 patient ePRO]( "Trends Shaping The Pharmaceutical Industry's Future")
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
![GettyImages-1315159023 oncology ps]( "Addressing The Specific Complexities Of Oncology eCOA Clinical Trials")
What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
![Business Globe Magnifier]( "Calling All Assessment Authors: Do You Want To Share Your COA With Sponsors Across The Globe?")
Explore how eCOAs will become an effective way to capture data remotely throughout the trial as sponsors shift to decentralized clinical trials.
-
![GettyImages-1169656849 eCOA]( "Setting Up An eCOA Trial In A DCT Context: What You Should Know")
Consider these three aspects when choosing an electronic Clinical Outcome Assessments (eCOA) provider and preparing to set up an eCOA clinical trial.
-
![Medical data ipad iStock-1182616138]( "How To Use Real World Data To Maximize Patient Recruitment In DCTs")
In the clinical trial space, RWD helps support research design, protocol and patient engagement goals. Perhaps the most immediate way clinical research leaders can harness the power of RWD is as a tool for optimized patient recruitment. Learn how this can be done in the available blog.
-
![GettyImages-2081140990-phone-cellphone-hand]( "How To Improve Patient Outcomes Using eSource Software In Clinical Trials")
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.
